TipHub

0.99

+0.04 +4.21%

As of 28 Jul 2026 · delayed

BSE Listed

GSM · GSM 0 · LT-ASM · ASM 1
What does GSM · GSM 0 · LT-ASM · ASM 1 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-06-24

Amerise Biosciences Limited (531681)

Volume: 1,84,442Avg Vol 1W: 85,707Avg Vol 1M: 81,70652W Range:0.50.99
Key Ratios
Checked 9h ago
Market Cap₹6 Cr
Current Price₹0.99
Previous Close₹0.95
High / Low (52w)₹0.99 / ₹0.5
Volume1,84,442
Avg Vol (1W)85,707
Avg Vol (1M)81,706
Stock P/E
Book Value₹0.82
Dividend Yield0%
ROE29.84%
ROA26.95%
Revenue (TTM)
Revenue Growth
Profit Margin0%
Total Debt
Shares Outstanding7 Cr
Face Value
EPS (TTM)₹0
P/B1.16
Debt / Equity0
50 DMA₹0.79
200 DMA₹0.69
Day change+4.21%
SurveillanceGSM · GSM 0 · LT-ASM · ASM 1
Price Chart
0.99 41.43% · 1Y
117.9L
2025-07-29
2026-07-28

20-day avg volume: 85K shares

Pros
  • Healthy return on equity of 29.8%.
  • Company is almost debt-free.
  • Revenue grew 424% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹10 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr
EPS-00-0.02-0.050.08-0.02-0.020
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹12 Cr₹6 Cr₹5 Cr₹8 Cr
Total Liabilities₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹6 Cr₹0 Cr₹0 Cr₹3 Cr
Equity₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹3 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-3 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹3 Cr
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE0.4%
Interest Coverage0
Dividend Payout
Debtor Days
Inventory Days
Payable Days
Cash Conversion Cycle
Working Capital Days
Shareholding Details

As of 2026-06-30

Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge
No. of Shareholders33,848
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters0%0%0%0%0%0%0%0%0%0%0%0%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public100%100%100%100%100%100%100%100%100%100%100%100%
Promoter Pledge
No. of Shareholders20,43520,83123,48523,32327,07735,14236,59536,21735,67635,18034,51933,848
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Amrapali Industries LimitedPublic Shareholding4.4%29,09,206
Jagkarta Agencies Private LimitedPublic Shareholding4.1%27,18,000
Dristi Fashions Private LimitedPublic Shareholding4.1%27,00,000
Twist Barter Private LimitedPublic Shareholding4.1%27,05,515
Sneha Sanjeev LunkadPublic Shareholding3.8%25,00,024
Kamna Coal Private LimitedPublic Shareholding3.1%20,31,631
Amrapali Fincap LimitedPublic Shareholding2.8%18,63,902
Snehjeev Ventures Private LimitedPublic Shareholding2.3%14,86,807
Riddhi LunkadPublic Shareholding2.1%13,85,714
Compact Fashions Private LimitedPublic Shareholding1.9%12,73,376
Destiny Procon Private LimitedPublic Shareholding1.9%12,19,000
Board of Directors
NameDesignationYear
Dineshkumar Tribhovanbhai RathodWhole Time Director & CFO2025
Kelash BunkarIndependent Non Exe. Director2025
Manisha Maneklal PatelIndependent Non Exe. Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1877
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-03Board Meetings
Substantial Acquisitions (SAST)

2 disclosure(s)

Margin04/06/2026 · 32,000
Market24/04/2026 · 5,60,000
Company Information
Incorporated1984
AuditorBipin & Co
Investor Email[email protected]
🌐 www.amerisebiosciencesltd.shop

📍 PO5-02D 5th Floor Tower A WTC, Gift City, Gandhinagar, Gujarat, 382355

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search